Sionna Therapeutics启动精确CF II期临床试验,评估Nbd1稳定剂Sion-719与标准治疗联合应用效果

美股速递
Oct 21, 2025

Sionna Therapeutics宣布启动精确CF II期临床试验,评估Nbd1稳定剂Sion-719在治疗囊性纤维化患者时与标准治疗相结合的效果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10